[Effect of a new liver therapeutic (ES 914) on allylalcohol damaged rat liver].
D000284:Administration, Oral; D000435:Alcoholic Intoxication / Q000188:drug therapy*; D000438:Alcohols; D000498:Allyl Compounds; D000704:Analysis of Variance; D000818:Animals; D001219:Aspartate Aminotransferases / Q000032:analysis; D002208:Caproates / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D002794:Choline / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000201:enzymology; D008110:Liver Extracts / Q000627:therapeutic use; D008715:Methionine / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains
D000438:Alcohols; D000498:Allyl Compounds; D002208:Caproates; D008110:Liver Extracts; D008715:Methionine; D001219:Aspartate Aminotransferases; D002794:Choline
Wirkung eines neuen Lebertherapeutikums (ES 914) auf die Schädigung der Rattenleber durch Alylalkohol.